Bellus reports 3Q loss
LAVAL, Quebec (AP) _ Bellus Health Inc. (BLUSF) on Wednesday reported a loss of $1.3 million in its third quarter.
On a per-share basis, the Laval, Quebec-based company said it had a loss of 2 cents.
The drug developer posted revenue of $74,200 in the period. Its adjusted revenue was $74,000.
The company's shares closed at 32 cents. A year ago, they were trading at 20 cents.